{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:17:34Z","timestamp":1791393454483,"version":"4.3.3"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4017,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Preliminary reports suggested that hepatitis C virus (HCV) infection has a more aggressive course following living donor liver transplantation (LDLT) compared to cadaveric liver transplantation (CLT). The aim of this prospective study was to establish if HCV disease recurrence differs between LDLT and CLT. A cohort of 116 consecutive HCV-infected patients undergoing 117 LTs in a single center from March 2000 to August 2003 were followed-up, including systematic liver biopsies. Severe recurrence (SR) was defined as biopsy-proven cirrhosis and\/or the occurrence of clinical decompensation. After a median follow-up of 22 months (2.6-44 months), 26 (22%) patients developed SR (decompensation in 12), involving 17 (18%) of 95 patients undergoing CLT and 9 (41%) of 22 undergoing LDLT. The 2-year probability of presenting SR was significantly higher in LDLT compared to CLT (45% vs. 22%, <jats:italic toggle=\"yes\">P<\/jats:italic> = .019). By univariate analysis LDLT (<jats:italic toggle=\"yes\">P<\/jats:italic> = .019) and an ALT higher than 80 IU\/L 3 months after LT (<jats:italic toggle=\"yes\">P<\/jats:italic> = .022) were predictors of SR. In 93 patients from whom a liver biopsy was available 3 months after LT, a lobular necroinflammatory score &gt;1 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .01), LDLT (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .01), and biliary complications (<jats:italic toggle=\"yes\">P<\/jats:italic> = .046) were associated with SR. However, the only variables independently associated with SR were LDLT (odds ratio [OR], = 2.8; 95% CI,1.19-6.6; <jats:italic toggle=\"yes\">P<\/jats:italic> = .024) and a lobular necroinflammatory score &gt;1 (OR, 3.1; 95% CI, 1.2-8; <jats:italic toggle=\"yes\">P<\/jats:italic> = .013). <jats:underline>In conclusion<\/jats:underline>, HCV recurrence is more severe in LDLT compared to CLT. Although our results were based on a single-center experience, they should be considered in the decision-making process of transplant programs, since severe HCV recurrence may ultimately compromise graft and patient survival. (Hepatology 2004; 40:699-707.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.20357","type":"journal-article","created":{"date-parts":[[2004,8,30]],"date-time":"2004-08-30T18:00:45Z","timestamp":1093888845000},"page":"699-707","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":161,"title":["Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation"],"prefix":"10.1097","volume":"40","author":[{"given":"Montserrat","family":"Garcia-Retortillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Forns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Llovet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Navasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Massaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Bruguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Garcia-Valdecasas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Rimola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20241201","doi-asserted-by":"crossref","first-page":"12311243","DOI":"10.1016\/j.lts.2003.09.018","article-title":"Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry.","volume":"9","author":"Adam","year":"2003","journal-title":"Liver Transpl"},{"issue":"Suppl","key":"R2-28-20241201","first-page":"S1S9","article-title":"Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.","volume":"9","author":"Wiesner","year":"2003","journal-title":"Liver Transpl"},{"key":"R3-28-20241201","doi-asserted-by":"crossref","first-page":"680687","DOI":"10.1053\/jhep.2002.31773","article-title":"Hepatitis C virus kinetics during and immediately after liver transplantation.","volume":"35","author":"Garcia-Retortillo","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R4-28-20241201","first-page":"673684","article-title":"HCV-related fibrosis progression following liver transplantation: increase in recent years.","volume":"32","author":"Berenguer","year":"2000","journal-title":"J Hepatol"},{"key":"R5-28-20241201","doi-asserted-by":"crossref","first-page":"250256","DOI":"10.1002\/hep.510290122","article-title":"High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.","volume":"29","author":"Prieto","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R6-28-20241201","doi-asserted-by":"crossref","first-page":"88996","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation.","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"R7-28-20241201","doi-asserted-by":"crossref","first-page":"756763","DOI":"10.1016\/S0168-8278(98)80224-9","article-title":"Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection.","volume":"28","author":"Berenguer","year":"1998","journal-title":"J Hepatol"},{"key":"R8-28-20241201","doi-asserted-by":"crossref","first-page":"202210","DOI":"10.1053\/jhep.2002.33993","article-title":"Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.","volume":"36","author":"Berenguer","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R9-28-20241201","doi-asserted-by":"crossref","first-page":"418426","DOI":"10.1053\/jhep.2000.9408","article-title":"Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.","volume":"32","author":"Pelletier","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R10-28-20241201","doi-asserted-by":"crossref","first-page":"818825","DOI":"10.1056\/NEJMsa021345","article-title":"A survey of liver transplantation from living adult donors in the United States.","volume":"348","author":"Brown","year":"2003","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"R11-28-20241201","first-page":"S69S72","article-title":"Regulation and oversight of adult living donor liver transplantation.","volume":"9","author":"Miller","year":"2003","journal-title":"Liver Transpl"},{"issue":"Suppl","key":"R12-28-20241201","first-page":"S73S79","article-title":"Future of adult living donor liver transplantation.","volume":"9","author":"Ghobrial","year":"2003","journal-title":"Liver Transpl"},{"issue":"Suppl","key":"R13-28-20241201","first-page":"S2S7","article-title":"Selection of donors for living donor liver transplantation.","volume":"9","author":"Trotter","year":"2003","journal-title":"Liver Transpl"},{"key":"R14-28-20241201","first-page":"C64A","article-title":"Living donor liver transplantation for hepatocellular carcinoma with explanted criteria: evaluation of applicability in Europe. abstract.","volume":"9","author":"Llovet","year":"2003","journal-title":"Liver Transpl"},{"key":"R15-28-20241201","doi-asserted-by":"crossref","first-page":"61622","DOI":"10.1097\/00007890-200202270-00025","article-title":"Cost-effectiveness of cadaveric and living-donor liver transplantation.","volume":"73","author":"Sagmeister","year":"2002","journal-title":"Transplantation"},{"key":"R16-28-20241201","doi-asserted-by":"crossref","first-page":"473476","DOI":"10.1097\/01.TP.0000047310.04069.ED","article-title":"Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation.","volume":"75","author":"Trotter","year":"2003","journal-title":"Transplantation"},{"key":"R17-28-20241201","doi-asserted-by":"crossref","first-page":"10731079","DOI":"10.1053\/jhep.2001.23311","article-title":"Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective.","volume":"33","author":"Sarasin","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R18-28-20241201","doi-asserted-by":"crossref","first-page":"340346","DOI":"10.1002\/lt.20090","article-title":"Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States.","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl"},{"key":"R19-28-20241201","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1023\/B:DDAS.0000011599.78222.9e","article-title":"Hepatitis C virus recurrence in living donor liver transplant recipients.","volume":"49","author":"Rodriguez-Luna","year":"2004","journal-title":"Dig Dis Sci"},{"key":"R20-28-20241201","doi-asserted-by":"crossref","first-page":"10661070","DOI":"10.1097\/01.TP.0000122142.00818.9E","article-title":"Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus.","volume":"77","author":"Bozorgzadeh","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl","key":"R21-28-20241201","first-page":"S64S68","article-title":"Role of adult living donor liver transplantation in patients with hepatitis C.","volume":"9","author":"Everson","year":"2003","journal-title":"Liver Transpl"},{"key":"R22-28-20241201","doi-asserted-by":"crossref","first-page":"10281035","DOI":"10.1053\/jlts.2003.50211","article-title":"Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors.","volume":"9","author":"Gaglio","year":"2003","journal-title":"Liver Transpl"},{"key":"R23-28-20241201","doi-asserted-by":"crossref","first-page":"519524","DOI":"10.1053\/jhep.2002.32089","article-title":"Prognostic prediction and treatment strategy in hepatocellular carcinoma.","volume":"35","author":"Bruix","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R24-28-20241201","doi-asserted-by":"crossref","first-page":"266275","DOI":"10.1002\/jmv.2029","article-title":"Influence of the dynamics of the hypervariable region 1 of the hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation.","volume":"65","author":"Sanchez-Fueyo","year":"2001","journal-title":"J Med Virol"},{"key":"R25-28-20241201","first-page":"658663","article-title":"Banff schema for grading liver allograft rejection: an international consensus document.","volume":"25","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R27-28-20241201","doi-asserted-by":"crossref","first-page":"112114","DOI":"10.1016\/0168-8278(95)80269-X","article-title":"The nomenclature of chronic hepatitis: time for a change.","volume":"22","author":"Scheuer","year":"1995","journal-title":"J Hepatol"},{"key":"R28-28-20241201","first-page":"15271533","article-title":"Single imaging modality evaluation of living donors in liver transplantation: magnetic resonance imaging.","volume":"72","author":"Cheng","year":"2001","journal-title":"Transplantation"},{"key":"R29-28-20241201","doi-asserted-by":"crossref","first-page":"210214","DOI":"10.1097\/01.TP.0000101007.59478.8B","article-title":"Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults.","volume":"77","author":"Van Vlierberghe","year":"2004","journal-title":"Transplantation"},{"key":"R30-28-20241201","doi-asserted-by":"crossref","first-page":"852858","DOI":"10.1053\/jhep.2000.17924","article-title":"Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation.","volume":"32","author":"Berenguer","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R31-28-20241201","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1053\/jhep.2003.50278","article-title":"A model to predict severe HCV-related disease following liver transplantation.","volume":"38","author":"Berenguer","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R32-28-20241201","doi-asserted-by":"crossref","first-page":"1282128","DOI":"10.1053\/jhep.2003.50449","article-title":"Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.","volume":"38","author":"Watashi","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R33-28-20241201","doi-asserted-by":"crossref","first-page":"640642","DOI":"10.1097\/00007890-199502270-00036","article-title":"The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation.","volume":"59","author":"Manez","year":"1995","journal-title":"Transplantation"},{"key":"R34-28-20241201","doi-asserted-by":"crossref","first-page":"726732","DOI":"10.1097\/01.TP.0000116604.89083.2F","article-title":"Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage.","volume":"77","author":"Liu","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl","key":"R36-28-20241201","first-page":"S35S41","article-title":"Hepatic regeneration in living donor liver transplantation.","volume":"9","author":"Olthoff","year":"2003","journal-title":"Liver Transpl"},{"key":"R37-28-20241201","doi-asserted-by":"crossref","first-page":"152162","DOI":"10.1016\/S0016-5085(00)70424-0","article-title":"Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation.","volume":"118","author":"Honda","year":"2000","journal-title":"Gastroenterology"},{"key":"R38-28-20241201","doi-asserted-by":"crossref","first-page":"15131524","DOI":"10.1128\/JVI.78.3.1513-1524.2004","article-title":"Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis.","volume":"78","author":"Scholle","year":"2004","journal-title":"J Virol"},{"key":"R39-28-20241201","doi-asserted-by":"crossref","first-page":"60169","DOI":"10.1002\/jcp.1041560320","article-title":"Early induction of LDL receptor gene during rat liver regeneration.","volume":"156","author":"Bocchetta","year":"1993","journal-title":"J Cell Physiol"},{"key":"R40-28-20241201","doi-asserted-by":"crossref","first-page":"1276612771","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.","volume":"96","author":"Agnello","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R41-28-20241201","doi-asserted-by":"crossref","first-page":"14281436","DOI":"10.1016\/j.hep.2003.09.010","article-title":"Results of retransplantation for recurrent hepatitis C.","volume":"38","author":"Roayaie","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R42-28-20241201","doi-asserted-by":"crossref","first-page":"350355","DOI":"10.1053\/jlts.2002.31748","article-title":"A pilot study of the tolerability and efficacy of antiviral therapy in patients awaiting liver transplantation for hepatitis C.","volume":"8","author":"Crippin","year":"2002","journal-title":"Liver Transpl"},{"key":"R43-28-20241201","first-page":"297A","article-title":"Long-term outcome of patients with chronic hepatitis C and decompensated liver disease treated with the LADR protocol (low accelerating-dose regimen). abstract.","volume":"36","author":"Everson","year":"2002","journal-title":"Hepatology"},{"key":"R44-28-20241201","doi-asserted-by":"crossref","first-page":"389396","DOI":"10.1016\/S0168-8278(03)00310-6","article-title":"Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.","volume":"39","author":"Forns","year":"2003","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.20357","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200409000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:13:52Z","timestamp":1733055232000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200409000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.20357","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}